Advisors Preferred’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $995K | Hold |
2,200
| – | – | 0.16% | 100 |
|
|
2025
Q1 | $1.07M | Buy |
+2,200
| New | +$1.07M | 0.14% | 108 |
|
|
2023
Q4 | – | Sell |
-9,633
| Closed | -$3.35M | – | 299 |
|
|
2023
Q3 | $3.35M | Sell |
9,633
-7,353
| -43% | -$2.56M | 1.09% | 24 |
|
|
2023
Q2 | $5.9M | Buy |
+16,986
| New | +$5.9M | 1.46% | 14 |
|
|
2022
Q2 | – | Sell |
-2,921
| Closed | -$777K | – | 199 |
|
|
2022
Q1 | $777K | Buy |
+2,921
| New | +$777K | 0.06% | 63 |
|
|
2021
Q2 | – | Sell |
-913
| Closed | -$195K | – | 229 |
|
|
2021
Q1 | $195K | Buy |
+913
| New | +$195K | 0.03% | 125 |
|
|
2020
Q1 | – | Sell |
-205
| Closed | -$45K | – | 271 |
|
|
2019
Q4 | $45K | Buy |
+205
| New | +$45K | 0.01% | 192 |
|
|
2018
Q4 | – | Sell |
-392
| Closed | -$76K | – | 222 |
|
|
2018
Q3 | $76K | Buy |
+392
| New | +$76K | 0.03% | 105 |
|